Cerity Partners LLC increased its stake in Teleflex Incorporated (NYSE:TFX - Free Report) by 25.8% during the fourth quarter, according to its most recent filing with the Securities and Exchange Commission. The firm owned 16,822 shares of the medical technology company's stock after purchasing an additional 3,448 shares during the quarter. Cerity Partners LLC's holdings in Teleflex were worth $3,266,000 at the end of the most recent quarter.
Several other institutional investors have also bought and sold shares of TFX. Russell Investments Group Ltd. raised its stake in shares of Teleflex by 116.9% in the fourth quarter. Russell Investments Group Ltd. now owns 89,194 shares of the medical technology company's stock valued at $15,870,000 after buying an additional 48,064 shares during the period. Dynamic Technology Lab Private Ltd bought a new stake in Teleflex in the 4th quarter valued at about $272,000. Resona Asset Management Co. Ltd. purchased a new stake in Teleflex during the fourth quarter valued at about $2,471,000. Prudential PLC boosted its position in Teleflex by 50.8% during the fourth quarter. Prudential PLC now owns 10,703 shares of the medical technology company's stock worth $1,905,000 after purchasing an additional 3,604 shares during the period. Finally, Massachusetts Financial Services Co. MA increased its stake in shares of Teleflex by 38.1% in the fourth quarter. Massachusetts Financial Services Co. MA now owns 590,529 shares of the medical technology company's stock worth $105,102,000 after purchasing an additional 162,950 shares in the last quarter. Hedge funds and other institutional investors own 95.62% of the company's stock.
Analyst Upgrades and Downgrades
A number of analysts recently commented on TFX shares. StockNews.com cut shares of Teleflex from a "buy" rating to a "hold" rating in a research note on Friday, February 28th. Truist Financial reduced their price target on Teleflex from $149.00 to $140.00 and set a "hold" rating for the company in a research report on Friday, April 11th. Needham & Company LLC reissued a "hold" rating on shares of Teleflex in a report on Wednesday, March 12th. Citizens Jmp lowered Teleflex from an "outperform" rating to a "market perform" rating in a report on Thursday, February 27th. Finally, Morgan Stanley cut their price objective on shares of Teleflex from $275.00 to $191.00 and set an "overweight" rating for the company in a research report on Wednesday, March 5th. One research analyst has rated the stock with a sell rating, nine have given a hold rating and two have assigned a buy rating to the stock. According to data from MarketBeat, the stock has a consensus rating of "Hold" and an average price target of $169.63.
Get Our Latest Stock Report on TFX
Teleflex Price Performance
Shares of TFX stock traded up $1.36 during trading on Friday, hitting $129.57. The company had a trading volume of 476,216 shares, compared to its average volume of 620,618. Teleflex Incorporated has a 52 week low of $124.66 and a 52 week high of $249.91. The stock has a market capitalization of $6.01 billion, a price-to-earnings ratio of 25.76, a price-to-earnings-growth ratio of 1.73 and a beta of 1.19. The company has a quick ratio of 1.39, a current ratio of 2.42 and a debt-to-equity ratio of 0.37. The stock's 50-day moving average is $144.52 and its two-hundred day moving average is $178.76.
Teleflex (NYSE:TFX - Get Free Report) last issued its quarterly earnings results on Thursday, February 27th. The medical technology company reported $3.89 EPS for the quarter, topping analysts' consensus estimates of $3.86 by $0.03. Teleflex had a net margin of 7.85% and a return on equity of 14.19%. The firm had revenue of $795.40 million for the quarter, compared to analyst estimates of $813.24 million. As a group, analysts predict that Teleflex Incorporated will post 13.98 EPS for the current fiscal year.
Teleflex Dividend Announcement
The company also recently disclosed a quarterly dividend, which was paid on Monday, March 17th. Stockholders of record on Friday, March 7th were given a dividend of $0.34 per share. The ex-dividend date of this dividend was Friday, March 7th. This represents a $1.36 annualized dividend and a dividend yield of 1.05%. Teleflex's dividend payout ratio (DPR) is presently 95.77%.
About Teleflex
(
Free Report)
Teleflex Incorporated designs, develops, manufactures, and supplies single-use medical devices for common diagnostic and therapeutic procedures in critical care and surgical applications worldwide. The company provides vascular access products that comprise Arrow branded catheters, catheter navigation and tip positioning systems, and intraosseous access systems for the administration of intravenous therapies, the measurement of blood pressure, and the withdrawal of blood samples through a single puncture site.
Featured Articles

Before you consider Teleflex, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Teleflex wasn't on the list.
While Teleflex currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
MarketBeat's analysts have just released their top five short plays for April 2025. Learn which stocks have the most short interest and how to trade them. Enter your email address to see which companies made the list.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.